tradingkey.logo

Artivion Inc

AORT
View Detailed Chart
39.590USD
+0.130+0.33%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.88BMarket Cap
LossP/E TTM

Artivion Inc

39.590
+0.130+0.33%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.33%

5 Days

-2.89%

1 Month

-12.72%

6 Months

+22.68%

Year to Date

-13.20%

1 Year

+26.61%

View Detailed Chart

TradingKey Stock Score of Artivion Inc

Currency: USD Updated: 2026-02-06

Key Insights

Artivion Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 13 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 51.71.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Artivion Inc's Score

Industry at a Glance

Industry Ranking
13 / 205
Overall Ranking
84 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Artivion Inc Highlights

StrengthsRisks
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 23.82% year-on-year.
Undervalued
The company’s latest PE is -171.75, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 43.29M shares, increasing 0.07% quarter-over-quarter.
Held by Joel Greenblatt
Star Investor Joel Greenblatt holds 14.72K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.99.

Analyst Rating

Based on 7 analysts
Buy
Current Rating
51.714
Target Price
+31.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Artivion Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Artivion Inc Info

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Ticker SymbolAORT
CompanyArtivion Inc
CEOMackin (James Patrick)
Websitehttps://artivion.com/
KeyAI